Search results for "Thrombosis"
DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis
A meta-analysis compared three direct oral anticoagulants (DOACs) (apixaban, edoxaban, and rivaroxaban) to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://immattersacp.org/weekly/archives/2023/01/03/5.htm
3 Jan 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2024
MKSAP Quiz: Swollen leg and recent cancer treatment
A 68-year-old woman is evaluated in the emergency department for swelling in her right leg of 3 days' duration. She completed therapy for breast cancer 1 month ago. She takes no medications. Following a physical exam, what is the most appropriate test?
https://immattersacp.org/weekly/archives/2024/02/20/3.htm
20 Feb 2024
DynaMed Plus image quiz: Thrombosis
The left panel of this angiography shows thrombosis of the right carotid artery such as might occur in a patient who presents to the emergency department with an acute symptomatic ischemic stroke. The right panel demonstrates the return of vascular flow following successful thrombolysis, as might occur after the patient is treated with intravenous alteplase within 180 minutes of stroke onset. Post-thrombolytic therapy, what is this patient is most likely to have?
https://immattersacp.org/archives/2017/04/dynamed.htm
1 Apr 2017
Registration is open for ACP's live online POCUS Mentorship Program
From May through October 2024, internal medicine physicians can attend one-on-one mentored scanning sessions covering content across five key point-of-care ultrasound (POCUS) skill areas.
https://immattersacp.org/weekly/archives/2024/03/05/6.htm
5 Mar 2024
First medication for severe frostbite approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/04/first-medication-for-severe-frostbite-approved.htm
1 Apr 2024
MKSAP Quiz: Follow-up for deep venous thrombosis
A 42-year-old man arrives for three-month follow-up of a proximal right leg DVT after right tibia fracture. Thrombophilia evaluation was done, although not recommended by guidelines, and found an elevated plasma homocysteine level; genetic testing then found homozygosity for the C677T methylene tetrahydrofolate reductase (MTHFR) polymorphism. His only medication is warfarin. What is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2018/07/17/3.htm
17 Jul 2018
Home-based INR monitoring associated with fewer adverse events
An industry-funded, claims-based analysis found that patients on warfarin who tested their international normalized ratio (INR) at home had lower rates of stroke, thromboembolism, and major bleeding than patients whose INRs were measured at physicians' offices or in laboratories.
https://immattersacp.org/weekly/archives/2024/01/02/4.htm
2 Jan 2024
Managing DOACs in primary care
Primary care physicians play a crucial role in ongoing anticoagulation management, including educating patients about the signs of venous thromboembolism.
https://immattersacp.org/archives/2022/04/managing-doacs-in-primary-care.htm
1 Apr 2022
Vitamin K antagonist use associated with higher risk of thrombosis than bleeding in patients ages 80 and older
Compared with patients ages 70 to 79 years, those ages 80 to 89 years had a similar risk of bleeding, whereas patients ages 90 years or older had a mildly increased risk of bleeding, the study found. Patients in their 80s and 90s had a markedly higher risk of thrombosis than did patients in their 70s.
https://immattersacp.org/weekly/archives/2016/07/12/4.htm
12 Jul 2016